ARCH MED RES 润色咨询

ARCHIVES OF MEDICAL RESEARCH

出版年份：1992 年文章数：667 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：1.5% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=488948, encodeId=7bf9488948d9, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Fri Jun 15 17:16:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488947, encodeId=24cc48894eb5, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 15 17:15:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488452, encodeId=f2dc488452da, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Wed May 16 16:17:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488378, encodeId=9ff64883e83d, content=5天被拒。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 12 00:45:00 CST 2012, time=2012-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487430, encodeId=141948e43021, content=2012.2.24 投稿 <br> 2012.3.21 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Thu Mar 22 10:32:00 CST 2012, time=2012-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485406, encodeId=59f648540673, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission <br> 2011.11.14 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Nov 15 08:31:00 CST 2011, time=2011-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485402, encodeId=6ce6485402f0, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Mon Nov 14 21:13:00 CST 2011, time=2011-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485096, encodeId=bb4e48509648, content=审稿速度:2.0<br>经验分享：2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Sat Oct 29 20:28:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484371, encodeId=d8aa4843e131, content=2011.8.30 <br> 2011.9.12 underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Sep 13 08:53:00 CST 2011, time=2011-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814905, encodeId=56da81490567, content=侧重的研究方向没有“医学基础研究”这项，实际上，该期刊比较关注目前的医学基础研究的前沿问题。当然，新药开发方面的文章也可以尝试向其投稿。<br> 刊物对于母语非英语的作者要求不低，稿件的语句通顺，文段之间须逻辑连贯，表达方式最好地道些。建议投稿前寻找母语系英语的人士修改，或自己反复推敲、斟酌语句的表达方式。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Wed Jun 29 09:45:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2012-06-15 superalert

    2012.2.24 投稿
    2012.3.21 under review
    2012.5.15 major revision
    2012.6.15 re-submission

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=488948, encodeId=7bf9488948d9, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Fri Jun 15 17:16:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488947, encodeId=24cc48894eb5, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 15 17:15:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488452, encodeId=f2dc488452da, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Wed May 16 16:17:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488378, encodeId=9ff64883e83d, content=5天被拒。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 12 00:45:00 CST 2012, time=2012-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487430, encodeId=141948e43021, content=2012.2.24 投稿 <br> 2012.3.21 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Thu Mar 22 10:32:00 CST 2012, time=2012-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485406, encodeId=59f648540673, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission <br> 2011.11.14 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Nov 15 08:31:00 CST 2011, time=2011-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485402, encodeId=6ce6485402f0, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Mon Nov 14 21:13:00 CST 2011, time=2011-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485096, encodeId=bb4e48509648, content=审稿速度:2.0<br>经验分享：2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Sat Oct 29 20:28:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484371, encodeId=d8aa4843e131, content=2011.8.30 <br> 2011.9.12 underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Sep 13 08:53:00 CST 2011, time=2011-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814905, encodeId=56da81490567, content=侧重的研究方向没有“医学基础研究”这项，实际上，该期刊比较关注目前的医学基础研究的前沿问题。当然，新药开发方面的文章也可以尝试向其投稿。<br> 刊物对于母语非英语的作者要求不低，稿件的语句通顺，文段之间须逻辑连贯，表达方式最好地道些。建议投稿前寻找母语系英语的人士修改，或自己反复推敲、斟酌语句的表达方式。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Wed Jun 29 09:45:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2012-06-15 匿名用户

    2012.2.24 投稿
    2012.3.21 under review
    2012.5.15 major revision
    2012.6.15 re-submission

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=488948, encodeId=7bf9488948d9, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Fri Jun 15 17:16:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488947, encodeId=24cc48894eb5, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 15 17:15:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488452, encodeId=f2dc488452da, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Wed May 16 16:17:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488378, encodeId=9ff64883e83d, content=5天被拒。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 12 00:45:00 CST 2012, time=2012-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487430, encodeId=141948e43021, content=2012.2.24 投稿 <br> 2012.3.21 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Thu Mar 22 10:32:00 CST 2012, time=2012-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485406, encodeId=59f648540673, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission <br> 2011.11.14 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Nov 15 08:31:00 CST 2011, time=2011-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485402, encodeId=6ce6485402f0, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Mon Nov 14 21:13:00 CST 2011, time=2011-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485096, encodeId=bb4e48509648, content=审稿速度:2.0<br>经验分享：2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Sat Oct 29 20:28:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484371, encodeId=d8aa4843e131, content=2011.8.30 <br> 2011.9.12 underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Sep 13 08:53:00 CST 2011, time=2011-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814905, encodeId=56da81490567, content=侧重的研究方向没有“医学基础研究”这项，实际上，该期刊比较关注目前的医学基础研究的前沿问题。当然，新药开发方面的文章也可以尝试向其投稿。<br> 刊物对于母语非英语的作者要求不低，稿件的语句通顺，文段之间须逻辑连贯，表达方式最好地道些。建议投稿前寻找母语系英语的人士修改，或自己反复推敲、斟酌语句的表达方式。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Wed Jun 29 09:45:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2012-05-16 superalert

    2012.2.24 投稿
    2012.3.21 under review
    2012.5.15 major revision

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=488948, encodeId=7bf9488948d9, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Fri Jun 15 17:16:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488947, encodeId=24cc48894eb5, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 15 17:15:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488452, encodeId=f2dc488452da, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Wed May 16 16:17:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488378, encodeId=9ff64883e83d, content=5天被拒。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 12 00:45:00 CST 2012, time=2012-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487430, encodeId=141948e43021, content=2012.2.24 投稿 <br> 2012.3.21 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Thu Mar 22 10:32:00 CST 2012, time=2012-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485406, encodeId=59f648540673, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission <br> 2011.11.14 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Nov 15 08:31:00 CST 2011, time=2011-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485402, encodeId=6ce6485402f0, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Mon Nov 14 21:13:00 CST 2011, time=2011-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485096, encodeId=bb4e48509648, content=审稿速度:2.0<br>经验分享：2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Sat Oct 29 20:28:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484371, encodeId=d8aa4843e131, content=2011.8.30 <br> 2011.9.12 underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Sep 13 08:53:00 CST 2011, time=2011-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814905, encodeId=56da81490567, content=侧重的研究方向没有“医学基础研究”这项，实际上，该期刊比较关注目前的医学基础研究的前沿问题。当然，新药开发方面的文章也可以尝试向其投稿。<br> 刊物对于母语非英语的作者要求不低，稿件的语句通顺，文段之间须逻辑连贯，表达方式最好地道些。建议投稿前寻找母语系英语的人士修改，或自己反复推敲、斟酌语句的表达方式。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Wed Jun 29 09:45:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2012-05-12 匿名用户

    5天被拒。。。。。。。。。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=488948, encodeId=7bf9488948d9, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Fri Jun 15 17:16:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488947, encodeId=24cc48894eb5, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 15 17:15:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488452, encodeId=f2dc488452da, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Wed May 16 16:17:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488378, encodeId=9ff64883e83d, content=5天被拒。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 12 00:45:00 CST 2012, time=2012-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487430, encodeId=141948e43021, content=2012.2.24 投稿 <br> 2012.3.21 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Thu Mar 22 10:32:00 CST 2012, time=2012-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485406, encodeId=59f648540673, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission <br> 2011.11.14 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Nov 15 08:31:00 CST 2011, time=2011-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485402, encodeId=6ce6485402f0, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Mon Nov 14 21:13:00 CST 2011, time=2011-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485096, encodeId=bb4e48509648, content=审稿速度:2.0<br>经验分享：2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Sat Oct 29 20:28:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484371, encodeId=d8aa4843e131, content=2011.8.30 <br> 2011.9.12 underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Sep 13 08:53:00 CST 2011, time=2011-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814905, encodeId=56da81490567, content=侧重的研究方向没有“医学基础研究”这项，实际上，该期刊比较关注目前的医学基础研究的前沿问题。当然，新药开发方面的文章也可以尝试向其投稿。<br> 刊物对于母语非英语的作者要求不低，稿件的语句通顺，文段之间须逻辑连贯，表达方式最好地道些。建议投稿前寻找母语系英语的人士修改，或自己反复推敲、斟酌语句的表达方式。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Wed Jun 29 09:45:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2012-03-22 superalert

    2012.2.24 投稿
    2012.3.21 under review

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=488948, encodeId=7bf9488948d9, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Fri Jun 15 17:16:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488947, encodeId=24cc48894eb5, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 15 17:15:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488452, encodeId=f2dc488452da, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Wed May 16 16:17:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488378, encodeId=9ff64883e83d, content=5天被拒。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 12 00:45:00 CST 2012, time=2012-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487430, encodeId=141948e43021, content=2012.2.24 投稿 <br> 2012.3.21 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Thu Mar 22 10:32:00 CST 2012, time=2012-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485406, encodeId=59f648540673, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission <br> 2011.11.14 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Nov 15 08:31:00 CST 2011, time=2011-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485402, encodeId=6ce6485402f0, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Mon Nov 14 21:13:00 CST 2011, time=2011-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485096, encodeId=bb4e48509648, content=审稿速度:2.0<br>经验分享：2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Sat Oct 29 20:28:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484371, encodeId=d8aa4843e131, content=2011.8.30 <br> 2011.9.12 underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Sep 13 08:53:00 CST 2011, time=2011-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814905, encodeId=56da81490567, content=侧重的研究方向没有“医学基础研究”这项，实际上，该期刊比较关注目前的医学基础研究的前沿问题。当然，新药开发方面的文章也可以尝试向其投稿。<br> 刊物对于母语非英语的作者要求不低，稿件的语句通顺，文段之间须逻辑连贯，表达方式最好地道些。建议投稿前寻找母语系英语的人士修改，或自己反复推敲、斟酌语句的表达方式。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Wed Jun 29 09:45:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-11-15 bioxc

    2011.8.30
    2011.9.12 underreview
    2011.10.29 major revision
    2011.11.11 submission
    2011.11.14 accept

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=488948, encodeId=7bf9488948d9, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Fri Jun 15 17:16:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488947, encodeId=24cc48894eb5, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 15 17:15:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488452, encodeId=f2dc488452da, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Wed May 16 16:17:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488378, encodeId=9ff64883e83d, content=5天被拒。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 12 00:45:00 CST 2012, time=2012-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487430, encodeId=141948e43021, content=2012.2.24 投稿 <br> 2012.3.21 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Thu Mar 22 10:32:00 CST 2012, time=2012-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485406, encodeId=59f648540673, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission <br> 2011.11.14 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Nov 15 08:31:00 CST 2011, time=2011-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485402, encodeId=6ce6485402f0, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Mon Nov 14 21:13:00 CST 2011, time=2011-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485096, encodeId=bb4e48509648, content=审稿速度:2.0<br>经验分享：2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Sat Oct 29 20:28:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484371, encodeId=d8aa4843e131, content=2011.8.30 <br> 2011.9.12 underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Sep 13 08:53:00 CST 2011, time=2011-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814905, encodeId=56da81490567, content=侧重的研究方向没有“医学基础研究”这项，实际上，该期刊比较关注目前的医学基础研究的前沿问题。当然，新药开发方面的文章也可以尝试向其投稿。<br> 刊物对于母语非英语的作者要求不低，稿件的语句通顺，文段之间须逻辑连贯，表达方式最好地道些。建议投稿前寻找母语系英语的人士修改，或自己反复推敲、斟酌语句的表达方式。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Wed Jun 29 09:45:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-11-14 bioxc

    2011.8.30
    2011.9.12 underreview
    2011.10.29 major revision
    2011.11.11 submission

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=488948, encodeId=7bf9488948d9, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Fri Jun 15 17:16:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488947, encodeId=24cc48894eb5, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 15 17:15:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488452, encodeId=f2dc488452da, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Wed May 16 16:17:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488378, encodeId=9ff64883e83d, content=5天被拒。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 12 00:45:00 CST 2012, time=2012-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487430, encodeId=141948e43021, content=2012.2.24 投稿 <br> 2012.3.21 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Thu Mar 22 10:32:00 CST 2012, time=2012-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485406, encodeId=59f648540673, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission <br> 2011.11.14 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Nov 15 08:31:00 CST 2011, time=2011-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485402, encodeId=6ce6485402f0, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Mon Nov 14 21:13:00 CST 2011, time=2011-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485096, encodeId=bb4e48509648, content=审稿速度:2.0<br>经验分享：2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Sat Oct 29 20:28:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484371, encodeId=d8aa4843e131, content=2011.8.30 <br> 2011.9.12 underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Sep 13 08:53:00 CST 2011, time=2011-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814905, encodeId=56da81490567, content=侧重的研究方向没有“医学基础研究”这项，实际上，该期刊比较关注目前的医学基础研究的前沿问题。当然，新药开发方面的文章也可以尝试向其投稿。<br> 刊物对于母语非英语的作者要求不低，稿件的语句通顺，文段之间须逻辑连贯，表达方式最好地道些。建议投稿前寻找母语系英语的人士修改，或自己反复推敲、斟酌语句的表达方式。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Wed Jun 29 09:45:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-10-29 bioxc

    审稿速度:2.0
    经验分享：2011.8.30
    2011.9.12 underreview
    2011.10.29 major revision

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=488948, encodeId=7bf9488948d9, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Fri Jun 15 17:16:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488947, encodeId=24cc48894eb5, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 15 17:15:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488452, encodeId=f2dc488452da, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Wed May 16 16:17:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488378, encodeId=9ff64883e83d, content=5天被拒。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 12 00:45:00 CST 2012, time=2012-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487430, encodeId=141948e43021, content=2012.2.24 投稿 <br> 2012.3.21 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Thu Mar 22 10:32:00 CST 2012, time=2012-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485406, encodeId=59f648540673, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission <br> 2011.11.14 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Nov 15 08:31:00 CST 2011, time=2011-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485402, encodeId=6ce6485402f0, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Mon Nov 14 21:13:00 CST 2011, time=2011-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485096, encodeId=bb4e48509648, content=审稿速度:2.0<br>经验分享：2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Sat Oct 29 20:28:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484371, encodeId=d8aa4843e131, content=2011.8.30 <br> 2011.9.12 underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Sep 13 08:53:00 CST 2011, time=2011-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814905, encodeId=56da81490567, content=侧重的研究方向没有“医学基础研究”这项，实际上，该期刊比较关注目前的医学基础研究的前沿问题。当然，新药开发方面的文章也可以尝试向其投稿。<br> 刊物对于母语非英语的作者要求不低，稿件的语句通顺，文段之间须逻辑连贯，表达方式最好地道些。建议投稿前寻找母语系英语的人士修改，或自己反复推敲、斟酌语句的表达方式。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Wed Jun 29 09:45:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-09-13 bioxc

    2011.8.30
    2011.9.12 underreview

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=488948, encodeId=7bf9488948d9, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Fri Jun 15 17:16:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488947, encodeId=24cc48894eb5, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision <br> 2012.6.15 re-submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Jun 15 17:15:00 CST 2012, time=2012-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488452, encodeId=f2dc488452da, content=2012.2.24 投稿 <br> 2012.3.21 under review <br> 2012.5.15 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=450, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Wed May 16 16:17:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488378, encodeId=9ff64883e83d, content=5天被拒。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 12 00:45:00 CST 2012, time=2012-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487430, encodeId=141948e43021, content=2012.2.24 投稿 <br> 2012.3.21 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=397a58748, createdName=superalert, createdTime=Thu Mar 22 10:32:00 CST 2012, time=2012-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485406, encodeId=59f648540673, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission <br> 2011.11.14 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Nov 15 08:31:00 CST 2011, time=2011-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485402, encodeId=6ce6485402f0, content=2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision <br> 2011.11.11 submission, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Mon Nov 14 21:13:00 CST 2011, time=2011-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485096, encodeId=bb4e48509648, content=审稿速度:2.0<br>经验分享：2011.8.30 <br> 2011.9.12 underreview <br> 2011.10.29 major revision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Sat Oct 29 20:28:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484371, encodeId=d8aa4843e131, content=2011.8.30 <br> 2011.9.12 underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bioxc, createdTime=Tue Sep 13 08:53:00 CST 2011, time=2011-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814905, encodeId=56da81490567, content=侧重的研究方向没有“医学基础研究”这项，实际上，该期刊比较关注目前的医学基础研究的前沿问题。当然，新药开发方面的文章也可以尝试向其投稿。<br> 刊物对于母语非英语的作者要求不低，稿件的语句通顺，文段之间须逻辑连贯，表达方式最好地道些。建议投稿前寻找母语系英语的人士修改，或自己反复推敲、斟酌语句的表达方式。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Wed Jun 29 09:45:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-06-29 ms7260643641707155

    侧重的研究方向没有“医学基础研究”这项，实际上，该期刊比较关注目前的医学基础研究的前沿问题。当然，新药开发方面的文章也可以尝试向其投稿。
    刊物对于母语非英语的作者要求不低，稿件的语句通顺，文段之间须逻辑连贯，表达方式最好地道些。建议投稿前寻找母语系英语的人士修改，或自己反复推敲、斟酌语句的表达方式。

    0

共94条页码: 5/10页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分